<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1990-04-01" modified="2017-05-10" version="225">
<accession>P14618</accession>
<accession>A6NFK3</accession>
<accession>B2R5N8</accession>
<accession>B3KRY0</accession>
<accession>B4DFX8</accession>
<accession>B4DUU6</accession>
<accession>P14786</accession>
<accession>Q53GK4</accession>
<accession>Q96E76</accession>
<accession>Q9BWB5</accession>
<accession>Q9UCV6</accession>
<accession>Q9UPF2</accession>
<name>KPYM_HUMAN</name>
<protein>
<recommendedName>
<fullName>Pyruvate kinase PKM</fullName>
<ecNumber>2.7.1.40</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Cytosolic thyroid hormone-binding protein</fullName>
<shortName>CTHBP</shortName>
</alternativeName>
<alternativeName>
<fullName>Opa-interacting protein 3</fullName>
<shortName>OIP-3</shortName>
</alternativeName>
<alternativeName>
<fullName>Pyruvate kinase 2/3</fullName>
</alternativeName>
<alternativeName>
<fullName>Pyruvate kinase muscle isozyme</fullName>
</alternativeName>
<alternativeName>
<fullName>Thyroid hormone-binding protein 1</fullName>
<shortName>THBP1</shortName>
</alternativeName>
<alternativeName>
<fullName>Tumor M2-PK</fullName>
</alternativeName>
<alternativeName>
<fullName>p58</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">PKM</name>
<name type="synonym">OIP3</name>
<name type="synonym">PK2</name>
<name type="synonym">PK3</name>
<name type="synonym">PKM2</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1988" name="Gene" volume="73" first="509" last="516">
<title>Human M2-type pyruvate kinase: cDNA cloning, chromosomal assignment and expression in hepatoma.</title>
<authorList>
<person name="Tani K."/>
<person name="Yoshida M.C."/>
<person name="Satoh H."/>
<person name="Mitamura K."/>
<person name="Noguchi T."/>
<person name="Tanaka T."/>
<person name="Fujii H."/>
<person name="Miwa S."/>
</authorList>
<dbReference type="PubMed" id="2854097"/>
<dbReference type="DOI" id="10.1016/0378-1119(88)90515-X"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM M2)</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1989" name="Proc. Natl. Acad. Sci. U.S.A." volume="86" first="7861" last="7865">
<title>Cytosolic thyroid hormone-binding protein is a monomer of pyruvate kinase.</title>
<authorList>
<person name="Kato H."/>
<person name="Fukuda T."/>
<person name="Parkison C."/>
<person name="McPhie P."/>
<person name="Cheng S.-Y."/>
</authorList>
<dbReference type="PubMed" id="2813362"/>
<dbReference type="DOI" id="10.1073/pnas.86.20.7861"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM M2)</scope>
<scope>PROTEIN SEQUENCE OF 70-98</scope>
<scope>SUBUNIT</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1990" name="Proc. Natl. Acad. Sci. U.S.A." volume="87" first="1625" last="1625">
<authorList>
<person name="Kato H."/>
<person name="Fukuda T."/>
<person name="Parkison C."/>
<person name="McPhie P."/>
<person name="Cheng S.-Y."/>
</authorList>
</citation>
<scope>ERRATUM</scope>
</reference>
<reference key="4">
<citation type="journal article" date="1991" name="Eur. J. Biochem." volume="198" first="101" last="106">
<title>Isolation and characterization of the human pyruvate kinase M gene.</title>
<authorList>
<person name="Takenaka M."/>
<person name="Noguchi T."/>
<person name="Sadahiro S."/>
<person name="Hirai H."/>
<person name="Yamada K."/>
<person name="Matsuda T."/>
<person name="Imai E."/>
<person name="Tanaka T."/>
</authorList>
<dbReference type="PubMed" id="2040271"/>
<dbReference type="DOI" id="10.1111/j.1432-1033.1991.tb15991.x"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>ALTERNATIVE SPLICING</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS M1 AND 3)</scope>
<source>
<tissue>Astrocyte</tissue>
<tissue>Fetal brain</tissue>
</source>
</reference>
<reference key="6">
<citation type="submission" date="2005-04" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Suzuki Y."/>
<person name="Sugano S."/>
<person name="Totoki Y."/>
<person name="Toyoda A."/>
<person name="Takeda T."/>
<person name="Sakaki Y."/>
<person name="Tanaka A."/>
<person name="Yokoyama S."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM M2)</scope>
<source>
<tissue>Kidney</tissue>
</source>
</reference>
<reference key="7">
<citation type="submission" date="2003-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIEHS SNPs program"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2006" name="Nature" volume="440" first="671" last="675">
<title>Analysis of the DNA sequence and duplication history of human chromosome 15.</title>
<authorList>
<person name="Zody M.C."/>
<person name="Garber M."/>
<person name="Sharpe T."/>
<person name="Young S.K."/>
<person name="Rowen L."/>
<person name="O'Neill K."/>
<person name="Whittaker C.A."/>
<person name="Kamal M."/>
<person name="Chang J.L."/>
<person name="Cuomo C.A."/>
<person name="Dewar K."/>
<person name="FitzGerald M.G."/>
<person name="Kodira C.D."/>
<person name="Madan A."/>
<person name="Qin S."/>
<person name="Yang X."/>
<person name="Abbasi N."/>
<person name="Abouelleil A."/>
<person name="Arachchi H.M."/>
<person name="Baradarani L."/>
<person name="Birditt B."/>
<person name="Bloom S."/>
<person name="Bloom T."/>
<person name="Borowsky M.L."/>
<person name="Burke J."/>
<person name="Butler J."/>
<person name="Cook A."/>
<person name="DeArellano K."/>
<person name="DeCaprio D."/>
<person name="Dorris L. III"/>
<person name="Dors M."/>
<person name="Eichler E.E."/>
<person name="Engels R."/>
<person name="Fahey J."/>
<person name="Fleetwood P."/>
<person name="Friedman C."/>
<person name="Gearin G."/>
<person name="Hall J.L."/>
<person name="Hensley G."/>
<person name="Johnson E."/>
<person name="Jones C."/>
<person name="Kamat A."/>
<person name="Kaur A."/>
<person name="Locke D.P."/>
<person name="Madan A."/>
<person name="Munson G."/>
<person name="Jaffe D.B."/>
<person name="Lui A."/>
<person name="Macdonald P."/>
<person name="Mauceli E."/>
<person name="Naylor J.W."/>
<person name="Nesbitt R."/>
<person name="Nicol R."/>
<person name="O'Leary S.B."/>
<person name="Ratcliffe A."/>
<person name="Rounsley S."/>
<person name="She X."/>
<person name="Sneddon K.M.B."/>
<person name="Stewart S."/>
<person name="Sougnez C."/>
<person name="Stone S.M."/>
<person name="Topham K."/>
<person name="Vincent D."/>
<person name="Wang S."/>
<person name="Zimmer A.R."/>
<person name="Birren B.W."/>
<person name="Hood L."/>
<person name="Lander E.S."/>
<person name="Nusbaum C."/>
</authorList>
<dbReference type="PubMed" id="16572171"/>
<dbReference type="DOI" id="10.1038/nature04601"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="9">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM M2)</scope>
<scope>VARIANT VAL-204</scope>
<source>
<tissue>Kidney</tissue>
<tissue>Lung carcinoma</tissue>
<tissue>Ovary</tissue>
<tissue>Retina</tissue>
<tissue>Rhabdomyosarcoma</tissue>
</source>
</reference>
<reference key="11">
<citation type="submission" date="2005-07" db="UniProtKB">
<authorList>
<person name="Bienvenut W.V."/>
</authorList>
</citation>
<scope>PROTEIN SEQUENCE OF 2-43; 57-73; 93-115; 126-135; 167-186; 231-246; 271-311; 401-422; 448-455 AND 490-498</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE</scope>
<scope>ACETYLATION AT SER-2</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<source>
<tissue>B-cell lymphoma</tissue>
</source>
</reference>
<reference key="12">
<citation type="journal article" date="1991" name="Biochemistry" volume="30" first="7105" last="7111">
<title>An in vitro novel mechanism of regulating the activity of pyruvate kinase M2 by thyroid hormone and fructose 1, 6-bisphosphate.</title>
<authorList>
<person name="Ashizawa K."/>
<person name="McPhie P."/>
<person name="Lin K.-H."/>
<person name="Cheng S.-Y."/>
</authorList>
<dbReference type="PubMed" id="1854723"/>
<dbReference type="DOI" id="10.1021/bi00243a010"/>
</citation>
<scope>PROTEIN SEQUENCE OF 2-18</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>ENZYME REGULATION</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
<scope>SUBUNIT</scope>
<scope>INTERACTION WITH THYROID HORMONE</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2003" name="Nat. Biotechnol." volume="21" first="566" last="569">
<title>Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides.</title>
<authorList>
<person name="Gevaert K."/>
<person name="Goethals M."/>
<person name="Martens L."/>
<person name="Van Damme J."/>
<person name="Staes A."/>
<person name="Thomas G.R."/>
<person name="Vandekerckhove J."/>
</authorList>
<dbReference type="PubMed" id="12665801"/>
<dbReference type="DOI" id="10.1038/nbt810"/>
</citation>
<scope>PROTEIN SEQUENCE OF 2-32</scope>
<source>
<tissue>Platelet</tissue>
</source>
</reference>
<reference key="14">
<citation type="submission" date="2007-03" db="UniProtKB">
<authorList>
<person name="Lubec G."/>
<person name="Vishwanath V."/>
</authorList>
</citation>
<scope>PROTEIN SEQUENCE OF 74-89</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<source>
<tissue>Brain</tissue>
<tissue>Cajal-Retzius cell</tissue>
</source>
</reference>
<reference key="15">
<citation type="journal article" date="2015" name="Oncogene" volume="34" first="3946" last="3956">
<title>TRIM35 Interacts with pyruvate kinase isoform M2 to suppress the Warburg effect and tumorigenicity in hepatocellular carcinoma.</title>
<authorList>
<person name="Chen Z."/>
<person name="Wang Z."/>
<person name="Guo W."/>
<person name="Zhang Z."/>
<person name="Zhao F."/>
<person name="Zhao Y."/>
<person name="Jia D."/>
<person name="Ding J."/>
<person name="Wang H."/>
<person name="Yao M."/>
<person name="He X."/>
</authorList>
<dbReference type="PubMed" id="25263439"/>
<dbReference type="DOI" id="10.1038/onc.2014.325"/>
</citation>
<scope>PROTEIN SEQUENCE OF 174-186; 295-305 AND 401-422 (ISOFORMS M2/3)</scope>
<scope>INTERACTION WITH TRIM35 (ISOFORM M2)</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MASS SPECTROMETRY</scope>
</reference>
<reference key="16">
<citation type="journal article" date="1998" name="Mol. Microbiol." volume="27" first="171" last="186">
<title>Using the yeast two-hybrid system to identify human epithelial cell proteins that bind gonococcal Opa proteins: intracellular gonococci bind pyruvate kinase via their Opa proteins and require host pyruvate for growth.</title>
<authorList>
<person name="Williams J.M."/>
<person name="Chen G.-C."/>
<person name="Zhu L."/>
<person name="Rest R.F."/>
</authorList>
<dbReference type="PubMed" id="9466265"/>
<dbReference type="DOI" id="10.1046/j.1365-2958.1998.00670.x"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 368-531 (ISOFORM M2)</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2003" name="FEBS Lett." volume="539" first="78" last="84">
<title>Interaction between HERC1 and M2-type pyruvate kinase.</title>
<authorList>
<person name="Garcia-Gonzalo F.R."/>
<person name="Cruz C."/>
<person name="Munoz P."/>
<person name="Mazurek S."/>
<person name="Eigenbrodt E."/>
<person name="Ventura F."/>
<person name="Bartrons R."/>
<person name="Rosa J.L."/>
</authorList>
<dbReference type="PubMed" id="12650930"/>
<dbReference type="DOI" id="10.1016/S0014-5793(03)00205-9"/>
</citation>
<scope>INTERACTION WITH HERC1</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2005" name="Biochem. Biophys. Res. Commun." volume="336" first="496" last="506">
<title>Proteomic identification of proteins conjugated to ISG15 in mouse and human cells.</title>
<authorList>
<person name="Giannakopoulos N.V."/>
<person name="Luo J.K."/>
<person name="Papov V."/>
<person name="Zou W."/>
<person name="Lenschow D.J."/>
<person name="Jacobs B.S."/>
<person name="Borden E.C."/>
<person name="Li J."/>
<person name="Virgin H.W."/>
<person name="Zhang D.E."/>
</authorList>
<dbReference type="PubMed" id="16139798"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2005.08.132"/>
</citation>
<scope>ISGYLATION</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2005" name="Nat. Biotechnol." volume="23" first="94" last="101">
<title>Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.</title>
<authorList>
<person name="Rush J."/>
<person name="Moritz A."/>
<person name="Lee K.A."/>
<person name="Guo A."/>
<person name="Goss V.L."/>
<person name="Spek E.J."/>
<person name="Zhang H."/>
<person name="Zha X.-M."/>
<person name="Polakiewicz R.D."/>
<person name="Comb M.J."/>
</authorList>
<dbReference type="PubMed" id="15592455"/>
<dbReference type="DOI" id="10.1038/nbt1046"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-105</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-37</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="21">
<citation type="journal article" date="2006" name="Nat. Biotechnol." volume="24" first="1285" last="1292">
<title>A probability-based approach for high-throughput protein phosphorylation analysis and site localization.</title>
<authorList>
<person name="Beausoleil S.A."/>
<person name="Villen J."/>
<person name="Gerber S.A."/>
<person name="Rush J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="16964243"/>
<dbReference type="DOI" id="10.1038/nbt1240"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-37</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="22">
<citation type="journal article" date="2007" name="Cancer Res." volume="67" first="1602" last="1608">
<title>Nuclear translocation of the tumor marker pyruvate kinase M2 induces programmed cell death.</title>
<authorList>
<person name="Stetak A."/>
<person name="Veress R."/>
<person name="Ovadi J."/>
<person name="Csermely P."/>
<person name="Keri G."/>
<person name="Ullrich A."/>
</authorList>
<dbReference type="PubMed" id="17308100"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-06-2870"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2008" name="Genes Cells" volume="13" first="245" last="254">
<title>Modulation of M2-type pyruvate kinase activity by the cytoplasmic PML tumor suppressor protein.</title>
<authorList>
<person name="Shimada N."/>
<person name="Shinagawa T."/>
<person name="Ishii S."/>
</authorList>
<dbReference type="PubMed" id="18298799"/>
<dbReference type="DOI" id="10.1111/j.1365-2443.2008.01165.x"/>
</citation>
<scope>INTERACTION WITH PML</scope>
<scope>ENZYME REGULATION</scope>
<scope>SUBUNIT</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2008" name="Int. J. Biochem. Cell Biol." volume="40" first="1043" last="1054">
<title>Pyruvate kinase isozyme type M2 (PKM2) interacts and cooperates with Oct-4 in regulating transcription.</title>
<authorList>
<person name="Lee J."/>
<person name="Kim H.K."/>
<person name="Han Y.-M."/>
<person name="Kim J."/>
</authorList>
<dbReference type="PubMed" id="18191611"/>
<dbReference type="DOI" id="10.1016/j.biocel.2007.11.009"/>
</citation>
<scope>INTERACTION WITH POU5F1</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="526" last="534">
<title>Phosphoproteome of resting human platelets.</title>
<authorList>
<person name="Zahedi R.P."/>
<person name="Lewandrowski U."/>
<person name="Wiesner J."/>
<person name="Wortelkamp S."/>
<person name="Moebius J."/>
<person name="Schuetz C."/>
<person name="Walter U."/>
<person name="Gambaryan S."/>
<person name="Sickmann A."/>
</authorList>
<dbReference type="PubMed" id="18088087"/>
<dbReference type="DOI" id="10.1021/pr0704130"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-37</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Platelet</tissue>
</source>
</reference>
<reference key="26">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-37</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="27">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-37</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="28">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-37; TYR-175 AND THR-195</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="30">
<citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
<title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
<authorList>
<person name="Choudhary C."/>
<person name="Kumar C."/>
<person name="Gnad F."/>
<person name="Nielsen M.L."/>
<person name="Rehman M."/>
<person name="Walther T.C."/>
<person name="Olsen J.V."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="19608861"/>
<dbReference type="DOI" id="10.1126/science.1175371"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-62; LYS-89; LYS-166; LYS-266 AND LYS-433</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-37</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="32">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2011" name="Cell" volume="145" first="732" last="744">
<title>Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1.</title>
<authorList>
<person name="Luo W."/>
<person name="Hu H."/>
<person name="Chang R."/>
<person name="Zhong J."/>
<person name="Knabel M."/>
<person name="O'Meally R."/>
<person name="Cole R.N."/>
<person name="Pandey A."/>
<person name="Semenza G.L."/>
</authorList>
<dbReference type="PubMed" id="21620138"/>
<dbReference type="DOI" id="10.1016/j.cell.2011.03.054"/>
</citation>
<scope>INTERACTION WITH EGLN3 AND HIF1A</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INDUCTION</scope>
<scope>FUNCTION</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>HYDROXYLATION AT PRO-403 AND PRO-408</scope>
<scope>MUTAGENESIS OF PRO-403 AND PRO-408</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2011" name="Cell Res." volume="21" first="983" last="986">
<title>The oxygen sensor PHD3 limits glycolysis under hypoxia via direct binding to pyruvate kinase.</title>
<authorList>
<person name="Chen N."/>
<person name="Rinner O."/>
<person name="Czernik D."/>
<person name="Nytko K.J."/>
<person name="Zheng D."/>
<person name="Stiehl D.P."/>
<person name="Zamboni N."/>
<person name="Gstaiger M."/>
<person name="Frei C."/>
</authorList>
<dbReference type="PubMed" id="21483450"/>
<dbReference type="DOI" id="10.1038/cr.2011.66"/>
</citation>
<scope>INTERACTION WITH EGLN3</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2011" name="Mol. Cell" volume="42" first="719" last="730">
<title>Acetylation targets the M2 isoform of pyruvate kinase for degradation through chaperone-mediated autophagy and promotes tumor growth.</title>
<authorList>
<person name="Lv L."/>
<person name="Li D."/>
<person name="Zhao D."/>
<person name="Lin R."/>
<person name="Chu Y."/>
<person name="Zhang H."/>
<person name="Zha Z."/>
<person name="Liu Y."/>
<person name="Li Z."/>
<person name="Xu Y."/>
<person name="Wang G."/>
<person name="Huang Y."/>
<person name="Xiong Y."/>
<person name="Guan K.L."/>
<person name="Lei Q.Y."/>
</authorList>
<dbReference type="PubMed" id="21700219"/>
<dbReference type="DOI" id="10.1016/j.molcel.2011.04.025"/>
</citation>
<scope>ACETYLATION AT LYS-305</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-37</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-37; THR-41; TYR-105 AND SER-127</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="38">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-37</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="39">
<citation type="journal article" date="2014" name="Mol. Cell. Proteomics" volume="13" first="372" last="387">
<title>Immunoaffinity enrichment and mass spectrometry analysis of protein methylation.</title>
<authorList>
<person name="Guo A."/>
<person name="Gu H."/>
<person name="Zhou J."/>
<person name="Mulhern D."/>
<person name="Wang Y."/>
<person name="Lee K.A."/>
<person name="Yang V."/>
<person name="Aguiar M."/>
<person name="Kornhauser J."/>
<person name="Jia X."/>
<person name="Ren J."/>
<person name="Beausoleil S.A."/>
<person name="Silva J.C."/>
<person name="Vemulapalli V."/>
<person name="Bedford M.T."/>
<person name="Comb M.J."/>
</authorList>
<dbReference type="PubMed" id="24129315"/>
<dbReference type="DOI" id="10.1074/mcp.O113.027870"/>
</citation>
<scope>METHYLATION [LARGE SCALE ANALYSIS] AT LYS-3</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Colon carcinoma</tissue>
</source>
</reference>
<reference key="40">
<citation type="journal article" date="2014" name="Proc. Natl. Acad. Sci. U.S.A." volume="111" first="12432" last="12437">
<title>Mapping of SUMO sites and analysis of SUMOylation changes induced by external stimuli.</title>
<authorList>
<person name="Impens F."/>
<person name="Radoshevich L."/>
<person name="Cossart P."/>
<person name="Ribet D."/>
</authorList>
<dbReference type="PubMed" id="25114211"/>
<dbReference type="DOI" id="10.1073/pnas.1413825111"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-166</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2015" name="Proteomics" volume="15" first="2519" last="2524">
<title>N-terminome analysis of the human mitochondrial proteome.</title>
<authorList>
<person name="Vaca Jacome A.S."/>
<person name="Rabilloud T."/>
<person name="Schaeffer-Reiss C."/>
<person name="Rompais M."/>
<person name="Ayoub D."/>
<person name="Lane L."/>
<person name="Bairoch A."/>
<person name="Van Dorsselaer A."/>
<person name="Carapito C."/>
</authorList>
<dbReference type="PubMed" id="25944712"/>
<dbReference type="DOI" id="10.1002/pmic.201400617"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2005" name="Biochemistry" volume="44" first="9417" last="9429">
<title>Structural basis for tumor pyruvate kinase M2 allosteric regulation and catalysis.</title>
<authorList>
<person name="Dombrauckas J.D."/>
<person name="Santarsiero B.D."/>
<person name="Mesecar A.D."/>
</authorList>
<dbReference type="PubMed" id="15996096"/>
<dbReference type="DOI" id="10.1021/bi0474923"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.82 ANGSTROMS) OF ISOFORM M2 IN COMPLEX WITH OXALATE AND FBP</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>SUBUNIT</scope>
<scope>ENZYME MECHANISM</scope>
<scope>ENZYME REGULATION</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
</reference>
<reference key="43">
<citation type="submission" date="2005-05" db="PDB data bank">
<title>Structure of human muscle pyruvate kinase (PKM2).</title>
<authorList>
<consortium name="Structural genomics consortium (SGC)"/>
</authorList>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS)</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2008" name="Nature" volume="452" first="181" last="186">
<title>Pyruvate kinase M2 is a phosphotyrosine-binding protein.</title>
<authorList>
<person name="Christofk H.R."/>
<person name="Vander Heiden M.G."/>
<person name="Wu N."/>
<person name="Asara J.M."/>
<person name="Cantley L.C."/>
</authorList>
<dbReference type="PubMed" id="18337815"/>
<dbReference type="DOI" id="10.1038/nature06667"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.03 ANGSTROMS) OF 14-531 ALONE AND IN COMPLEX WITH FBP</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2012" name="Nature" volume="491" first="458" last="462">
<title>Serine is a natural ligand and allosteric activator of pyruvate kinase M2.</title>
<authorList>
<person name="Chaneton B."/>
<person name="Hillmann P."/>
<person name="Zheng L."/>
<person name="Martin A.C."/>
<person name="Maddocks O.D."/>
<person name="Chokkathukalam A."/>
<person name="Coyle J.E."/>
<person name="Jankevics A."/>
<person name="Holding F.P."/>
<person name="Vousden K.H."/>
<person name="Frezza C."/>
<person name="O'Reilly M."/>
<person name="Gottlieb E."/>
</authorList>
<dbReference type="PubMed" id="23064226"/>
<dbReference type="DOI" id="10.1038/nature11540"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 2-531</scope>
<scope>ENZYME REGULATION BY SERINE</scope>
<scope>MAGNESIUM-BINDING SITES</scope>
<scope>SUBUNIT</scope>
<scope>MUTAGENESIS OF SER-437 AND HIS-464</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2013" name="Proc. Natl. Acad. Sci. U.S.A." volume="110" first="5881" last="5886">
<title>M2 pyruvate kinase provides a mechanism for nutrient sensing and regulation of cell proliferation.</title>
<authorList>
<person name="Morgan H.P."/>
<person name="O'Reilly F.J."/>
<person name="Wear M.A."/>
<person name="O'Neill J.R."/>
<person name="Fothergill-Gilmore L.A."/>
<person name="Hupp T."/>
<person name="Walkinshaw M.D."/>
</authorList>
<dbReference type="PubMed" id="23530218"/>
<dbReference type="DOI" id="10.1073/pnas.1217157110"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.55 ANGSTROMS) IN COMPLEX WITH ATP; FRUCTOSE-1-6-DIPHOSPHATE; MAGNESIUM IONS AND POTASSIUM IONS</scope>
</reference>
<comment type="function">
<text evidence="39 40 45">Glycolytic enzyme that catalyzes the transfer of a phosphoryl group from phosphoenolpyruvate (PEP) to ADP, generating ATP. Stimulates POU5F1-mediated transcriptional activation. Plays a general role in caspase independent cell death of tumor cells. The ratio between the highly active tetrameric form and nearly inactive dimeric form determines whether glucose carbons are channeled to biosynthetic processes or used for glycolytic ATP production. The transition between the 2 forms contributes to the control of glycolysis and is important for tumor cell proliferation and survival.</text>
</comment>
<comment type="catalytic activity">
<text evidence="37 43">ATP + pyruvate = ADP + phosphoenolpyruvate.</text>
</comment>
<comment type="cofactor">
<cofactor evidence="54">
<name>Mg(2+)</name>
<dbReference type="ChEBI" id="CHEBI:18420"/>
</cofactor>
</comment>
<comment type="cofactor">
<cofactor evidence="54">
<name>K(+)</name>
<dbReference type="ChEBI" id="CHEBI:29103"/>
</cofactor>
</comment>
<comment type="enzyme regulation">
<text evidence="37 41 42 43 47 50">Isoform M2 is allosterically activated by D-fructose 1,6-bisphosphate (FBP). Inhibited by oxalate and 3,3',5-triiodo-L-thyronine (T3). The activity of the tetrameric form is inhibited by PML. Selective binding to tyrosine-phosphorylated peptides releases the allosteric activator FBP, leading to inhibition of PKM enzymatic activity, this diverts glucose metabolites from energy production to anabolic processes when cells are stimulated by certain growth factors. Glycolytic flux are highly dependent on de novo biosynthesis of serine and glycine, and serine is a natural ligand and allosteric activator of isoform M2.</text>
</comment>
<comment type="biophysicochemical properties">
<kinetics>
<KM evidence="37 43">2.7 mM for phosphoenolpyruvate (at 32 degrees Celsius, pH 8.0)</KM>
<KM evidence="37 43">0.17 mM for phosphoenolpyruvate (in the presence of 2 mM D-fructose 1,6-bisphosphate (FBP), at 32 degrees Celsius, pH 8.0)</KM>
<KM evidence="37 43">0.34 mM for ADP (at 32 degrees Celsius, pH 8.0)</KM>
<KM evidence="37 43">0.24 mM for ADP (in the presence of 2 mM FBP, at 32 degrees Celsius, pH 8.0)</KM>
<KM evidence="37 43">0.13 mM for phosphoenolpyruvate (in the presence of 2 mM FBP, at 25 degrees Celsius)</KM>
<KM evidence="37 43">0.63 mM for ADP (in the presence of 2 mM FBP, at 25 degrees Celsius)</KM>
</kinetics>
<phDependence>
<text evidence="37 43">Optimum pH for T3 binding is 6.0-6.5. Increase in pH causes T3 binding to drop, does not bind T3 above pH 9.0 or below pH 5.0.</text>
</phDependence>
</comment>
<comment type="pathway">
<text>Carbohydrate degradation; glycolysis; pyruvate from D-glyceraldehyde 3-phosphate: step 5/5.</text>
</comment>
<comment type="subunit">
<text evidence="34 37 40 41 42 43 44 45 47 49 50">Monomer and homotetramer. Exists as a monomer in the absence of D-fructose 1,6-bisphosphate (FBP), and reversibly associates to form a homotetramer in the presence of FBP. The monomeric form binds T3. Tetramer formation induces pyruvate kinase activity. The tetrameric form has high affinity for the substrate and is associated within the glycolytic enzyme complex. Exists in a nearly inactive dimeric form in tumor cells and the dimeric form has less affinity for the substrate. Binding to certain oncoproteins such as HPV-16 E7 oncoprotein can trigger dimerization. FBP stimulates the formation of tetramers from dimers. Interacts with HERC1, POU5F1 and PML. Interacts (isoform M2) with EGLN3; the interaction hydroxylates PKM under hypoxia and enhances binding to HIF1A. Interacts (isoform M2) with HIF1A; the interaction is enhanced by binding of EGLN3, promoting enhanced transcription activity under hypoxia. Interacts (isoform M2, but not isoform M1) with TRIM35; this interaction prevents FGFR1-dependent tyrosine phosphorylation (PubMed:25263439).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-353408"/>
<interactant intactId="EBI-710918">
<id>Q9WMX2</id>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-353408"/>
<interactant intactId="EBI-365961">
<id>P10398</id>
<label>ARAF</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-353408"/>
<interactant intactId="EBI-743313">
<id>P49407</id>
<label>ARRB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-353408"/>
<interactant intactId="EBI-714559">
<id>P32121</id>
<label>ARRB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-353408"/>
<interactant intactId="EBI-358616">
<id>P53355</id>
<label>DAPK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-4304679"/>
<interactant intactId="EBI-1175354">
<id>Q9H6Z9</id>
<label>EGLN3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-4304679"/>
<interactant intactId="EBI-447269">
<id>Q16665</id>
<label>HIF1A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-4304679"/>
<interactant intactId="EBI-79722">
<id>P68431</id>
<label>HIST1H3D</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-353408"/>
<interactant intactId="EBI-466029">
<id>P42858</id>
<label>HTT</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-4304679"/>
<interactant intactId="EBI-73995">
<id>P27361</id>
<label>MAPK3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-353408"/>
<interactant intactId="EBI-365996">
<id>P04049</id>
<label>RAF1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-353408"/>
<interactant intactId="EBI-717399">
<id>Q9BSI4</id>
<label>TINF2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="49">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<text>Translocates to the nucleus in response to different apoptotic stimuli. Nuclear translocation is sufficient to induce cell death that is caspase independent, isoform-specific and independent of its enzymatic activity.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P14618-1</id>
<name>M2</name>
<name>M2-PK</name>
<name>PKM2</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P14618-2</id>
<id>P14786-1</id>
<name>M1</name>
<name>M1-PK</name>
<name>PKM1</name>
<sequence type="described" ref="VSP_011101"/>
</isoform>
<isoform>
<id>P14618-3</id>
<name>3</name>
<sequence type="described" ref="VSP_043370"/>
<text>No experimental confirmation available.</text>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="40">Specifically expressed in proliferating cells, such as embryonic stem cells, embryonic carcinoma cells, as well as cancer cells.</text>
</comment>
<comment type="PTM">
<text evidence="38">ISGylated.</text>
</comment>
<comment type="PTM">
<text evidence="45">Under hypoxia, hydroxylated by EGLN3.</text>
</comment>
<comment type="PTM">
<text evidence="46 51">Acetylation at Lys-305 is stimulated by high glucose concentration, it decreases enzyme activity and promotes its lysosomal-dependent degradation via chaperone-mediated autophagy.</text>
</comment>
<comment type="PTM">
<text evidence="49">FGFR1-dependent tyrosine phosphorylation is reduced by interaction with TRIM35.</text>
</comment>
<comment type="miscellaneous">
<text>There are 4 isozymes of pyruvate kinase in mammals (L, R, M1, M2) encoded by 2 different genes: PKLR and PKM. The L and R isozymes are generated from the PKLR by differential splicing of RNA; the M1 and M2 forms are produced from the PKM gene by differential splicing. L type is major isozyme in the liver, R is found in red cells, M1 is the main form in muscle, heart and brain, and M2 is found in early fetal tissues as well as in most cancer cells.</text>
</comment>
<comment type="similarity">
<text evidence="53">Belongs to the pyruvate kinase family.</text>
</comment>
<comment type="sequence caution" evidence="53">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="BAG57589" version="1"/>
</conflict>
<text>Translation N-terminally shortened.</text>
</comment>
<comment type="online information" name="NIEHS-SNPs">
<link uri="http://egp.gs.washington.edu/data/pkm2/"/>
</comment>
<comment type="online information" name="Wikipedia">
<link uri="https://en.wikipedia.org/wiki/Pyruvate_kinase"/>
<text>Pyruvate kinase entry</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/PKM2ID41728ch15q22.html"/>
</comment>
<dbReference type="EC" id="2.7.1.40"/>
<dbReference type="EMBL" id="M23725">
<property type="protein sequence ID" value="AAA36449.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M26252">
<property type="protein sequence ID" value="AAA36672.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X56494">
<property type="protein sequence ID" value="CAA39849.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AK092369">
<property type="protein sequence ID" value="BAG52542.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK222927">
<property type="protein sequence ID" value="BAD96647.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK294315">
<property type="protein sequence ID" value="BAG57589.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK300800">
<property type="protein sequence ID" value="BAG62458.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK312253">
<property type="protein sequence ID" value="BAG35185.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY352517">
<property type="protein sequence ID" value="AAQ15274.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC020779">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471082">
<property type="protein sequence ID" value="EAW77884.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471082">
<property type="protein sequence ID" value="EAW77888.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC000481">
<property type="protein sequence ID" value="AAH00481.3"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC007640">
<property type="protein sequence ID" value="AAH07640.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC007952">
<property type="protein sequence ID" value="AAH07952.3"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC012811">
<property type="protein sequence ID" value="AAH12811.3"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC035198">
<property type="protein sequence ID" value="AAH35198.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF025439">
<property type="protein sequence ID" value="AAC39559.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS32284.1">
<molecule id="P14618-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS32285.1">
<molecule id="P14618-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS55972.1">
<molecule id="P14618-3"/>
</dbReference>
<dbReference type="PIR" id="S30038">
<property type="entry name" value="S30038"/>
</dbReference>
<dbReference type="PIR" id="S64635">
<property type="entry name" value="S64635"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001193725.1">
<property type="nucleotide sequence ID" value="NM_001206796.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001193726.1">
<property type="nucleotide sequence ID" value="NM_001206797.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001193727.1">
<molecule id="P14618-3"/>
<property type="nucleotide sequence ID" value="NM_001206798.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001193728.1">
<property type="nucleotide sequence ID" value="NM_001206799.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001303247.1">
<property type="nucleotide sequence ID" value="NM_001316318.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_002645.3">
<molecule id="P14618-1"/>
<property type="nucleotide sequence ID" value="NM_002654.5"/>
</dbReference>
<dbReference type="RefSeq" id="NP_872270.1">
<molecule id="P14618-2"/>
<property type="nucleotide sequence ID" value="NM_182470.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_872271.1">
<molecule id="P14618-2"/>
<property type="nucleotide sequence ID" value="NM_182471.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005254502.1">
<molecule id="P14618-1"/>
<property type="nucleotide sequence ID" value="XM_005254445.4"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016877802.1">
<molecule id="P14618-2"/>
<property type="nucleotide sequence ID" value="XM_017022313.1"/>
</dbReference>
<dbReference type="UniGene" id="Hs.534770"/>
<dbReference type="UniGene" id="Hs.704299"/>
<dbReference type="PDB" id="1T5A">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A/B/C/D=1-531"/>
</dbReference>
<dbReference type="PDB" id="1ZJH">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A=3-531"/>
</dbReference>
<dbReference type="PDB" id="3BJF">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.03"/>
<property type="chains" value="A/B/C/D=14-531"/>
</dbReference>
<dbReference type="PDB" id="3BJT">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/B/C/D=2-531"/>
</dbReference>
<dbReference type="PDB" id="3G2G">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A/B/C/D=1-531"/>
</dbReference>
<dbReference type="PDB" id="3GQY">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.85"/>
<property type="chains" value="A/B/C/D=1-531"/>
</dbReference>
<dbReference type="PDB" id="3GR4">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.60"/>
<property type="chains" value="A/B/C/D=1-531"/>
</dbReference>
<dbReference type="PDB" id="3H6O">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A/B/C/D=1-531"/>
</dbReference>
<dbReference type="PDB" id="3ME3">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.95"/>
<property type="chains" value="A/B/C/D=1-531"/>
</dbReference>
<dbReference type="PDB" id="3SRD">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A/B/C/D=1-531"/>
</dbReference>
<dbReference type="PDB" id="3SRF">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.84"/>
<property type="chains" value="A/B/C/D/E/F/G/H=1-531"/>
</dbReference>
<dbReference type="PDB" id="3SRH">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A/B/C/D=1-531"/>
</dbReference>
<dbReference type="PDB" id="3U2Z">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A/B/C/D=1-531"/>
</dbReference>
<dbReference type="PDB" id="4B2D">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A/B/C/D=2-531"/>
</dbReference>
<dbReference type="PDB" id="4FXF">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.55"/>
<property type="chains" value="A/B/C/D=1-531"/>
</dbReference>
<dbReference type="PDB" id="4FXJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A/B/C/D=1-531"/>
</dbReference>
<dbReference type="PDB" id="4G1N">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A/B/C/D=14-531"/>
</dbReference>
<dbReference type="PDB" id="4JPG">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.33"/>
<property type="chains" value="A/B/C/D=1-531"/>
</dbReference>
<dbReference type="PDB" id="4QG6">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.21"/>
<property type="chains" value="A/B/C/D=1-531"/>
</dbReference>
<dbReference type="PDB" id="4QG8">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A/B/C/D=1-531"/>
</dbReference>
<dbReference type="PDB" id="4QG9">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.38"/>
<property type="chains" value="A/B/C/D=1-531"/>
</dbReference>
<dbReference type="PDB" id="4QGC">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A/B/C/D=1-531"/>
</dbReference>
<dbReference type="PDB" id="4RPP">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.58"/>
<property type="chains" value="A/B/C/D=1-531"/>
</dbReference>
<dbReference type="PDB" id="4WJ8">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.87"/>
<property type="chains" value="A/B/C/D=1-531"/>
</dbReference>
<dbReference type="PDB" id="4YJ5">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.41"/>
<property type="chains" value="A/B/C/D=14-531"/>
</dbReference>
<dbReference type="PDBsum" id="1T5A"/>
<dbReference type="PDBsum" id="1ZJH"/>
<dbReference type="PDBsum" id="3BJF"/>
<dbReference type="PDBsum" id="3BJT"/>
<dbReference type="PDBsum" id="3G2G"/>
<dbReference type="PDBsum" id="3GQY"/>
<dbReference type="PDBsum" id="3GR4"/>
<dbReference type="PDBsum" id="3H6O"/>
<dbReference type="PDBsum" id="3ME3"/>
<dbReference type="PDBsum" id="3SRD"/>
<dbReference type="PDBsum" id="3SRF"/>
<dbReference type="PDBsum" id="3SRH"/>
<dbReference type="PDBsum" id="3U2Z"/>
<dbReference type="PDBsum" id="4B2D"/>
<dbReference type="PDBsum" id="4FXF"/>
<dbReference type="PDBsum" id="4FXJ"/>
<dbReference type="PDBsum" id="4G1N"/>
<dbReference type="PDBsum" id="4JPG"/>
<dbReference type="PDBsum" id="4QG6"/>
<dbReference type="PDBsum" id="4QG8"/>
<dbReference type="PDBsum" id="4QG9"/>
<dbReference type="PDBsum" id="4QGC"/>
<dbReference type="PDBsum" id="4RPP"/>
<dbReference type="PDBsum" id="4WJ8"/>
<dbReference type="PDBsum" id="4YJ5"/>
<dbReference type="ProteinModelPortal" id="P14618"/>
<dbReference type="SMR" id="P14618"/>
<dbReference type="BioGrid" id="111332">
<property type="interactions" value="180"/>
</dbReference>
<dbReference type="DIP" id="DIP-31273N"/>
<dbReference type="IntAct" id="P14618">
<property type="interactions" value="242"/>
</dbReference>
<dbReference type="MINT" id="MINT-4998892"/>
<dbReference type="STRING" id="9606.ENSP00000320171"/>
<dbReference type="BindingDB" id="P14618"/>
<dbReference type="ChEMBL" id="CHEMBL1075189"/>
<dbReference type="DrugBank" id="DB02726">
<property type="generic name" value="2-Phosphoglycolic Acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB01733">
<property type="generic name" value="L-Phospholactate"/>
</dbReference>
<dbReference type="DrugBank" id="DB00119">
<property type="generic name" value="Pyruvic acid"/>
</dbReference>
<dbReference type="iPTMnet" id="P14618"/>
<dbReference type="PhosphoSitePlus" id="P14618"/>
<dbReference type="SwissPalm" id="P14618"/>
<dbReference type="BioMuta" id="PKM"/>
<dbReference type="DMDM" id="20178296"/>
<dbReference type="DOSAC-COBS-2DPAGE" id="P14618"/>
<dbReference type="OGP" id="P14618"/>
<dbReference type="REPRODUCTION-2DPAGE" id="IPI00220644"/>
<dbReference type="REPRODUCTION-2DPAGE" id="IPI00479186"/>
<dbReference type="UCD-2DPAGE" id="P14618"/>
<dbReference type="EPD" id="P14618"/>
<dbReference type="PaxDb" id="P14618"/>
<dbReference type="PeptideAtlas" id="P14618"/>
<dbReference type="PRIDE" id="P14618"/>
<dbReference type="TopDownProteomics" id="P14618-1">
<molecule id="P14618-1"/>
</dbReference>
<dbReference type="TopDownProteomics" id="P14618-2">
<molecule id="P14618-2"/>
</dbReference>
<dbReference type="DNASU" id="5315"/>
<dbReference type="Ensembl" id="ENST00000319622">
<molecule id="P14618-2"/>
<property type="protein sequence ID" value="ENSP00000320171"/>
<property type="gene ID" value="ENSG00000067225"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000335181">
<molecule id="P14618-1"/>
<property type="protein sequence ID" value="ENSP00000334983"/>
<property type="gene ID" value="ENSG00000067225"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000449901">
<molecule id="P14618-3"/>
<property type="protein sequence ID" value="ENSP00000403365"/>
<property type="gene ID" value="ENSG00000067225"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000565154">
<molecule id="P14618-2"/>
<property type="protein sequence ID" value="ENSP00000455901"/>
<property type="gene ID" value="ENSG00000067225"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000565184">
<molecule id="P14618-2"/>
<property type="protein sequence ID" value="ENSP00000455736"/>
<property type="gene ID" value="ENSG00000067225"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000568459">
<molecule id="P14618-2"/>
<property type="protein sequence ID" value="ENSP00000456970"/>
<property type="gene ID" value="ENSG00000067225"/>
</dbReference>
<dbReference type="GeneID" id="5315"/>
<dbReference type="KEGG" id="hsa:5315"/>
<dbReference type="UCSC" id="uc002atw.2">
<molecule id="P14618-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="5315"/>
<dbReference type="DisGeNET" id="5315"/>
<dbReference type="GeneCards" id="PKM"/>
<dbReference type="HGNC" id="HGNC:9021">
<property type="gene designation" value="PKM"/>
</dbReference>
<dbReference type="HPA" id="CAB019421"/>
<dbReference type="HPA" id="HPA029501"/>
<dbReference type="MalaCards" id="PKM"/>
<dbReference type="MIM" id="179050">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P14618"/>
<dbReference type="OpenTargets" id="ENSG00000067225"/>
<dbReference type="PharmGKB" id="PA33353"/>
<dbReference type="eggNOG" id="KOG2323">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG0469">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00390000008859"/>
<dbReference type="HOGENOM" id="HOG000021559"/>
<dbReference type="HOVERGEN" id="HBG000941"/>
<dbReference type="InParanoid" id="P14618"/>
<dbReference type="KO" id="K00873"/>
<dbReference type="OMA" id="KQHGGEH"/>
<dbReference type="PhylomeDB" id="P14618"/>
<dbReference type="TreeFam" id="TF300390"/>
<dbReference type="BioCyc" id="MetaCyc:HS00906-MONOMER"/>
<dbReference type="BRENDA" id="2.7.1.40">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6798695">
<property type="pathway name" value="Neutrophil degranulation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-70171">
<property type="pathway name" value="Glycolysis"/>
</dbReference>
<dbReference type="SABIO-RK" id="P14618"/>
<dbReference type="SIGNOR" id="P14618"/>
<dbReference type="UniPathway" id="UPA00109">
<property type="reaction ID" value="UER00188"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P14618"/>
<dbReference type="GeneWiki" id="PKM2"/>
<dbReference type="GenomeRNAi" id="5315"/>
<dbReference type="PRO" id="PR:P14618"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 15"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000067225"/>
<dbReference type="CleanEx" id="HS_PKM2"/>
<dbReference type="ExpressionAtlas" id="P14618">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P14618">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005929">
<property type="term" value="C:cilium"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031012">
<property type="term" value="C:extracellular matrix"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005576">
<property type="term" value="C:extracellular region"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:1903561">
<property type="term" value="C:extracellular vesicle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1904813">
<property type="term" value="C:ficolin-1-rich granule lumen"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005739">
<property type="term" value="C:mitochondrion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043209">
<property type="term" value="C:myelin sheath"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034774">
<property type="term" value="C:secretory granule lumen"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0031982">
<property type="term" value="C:vesicle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0045296">
<property type="term" value="F:cadherin binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0016301">
<property type="term" value="F:kinase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0000287">
<property type="term" value="F:magnesium ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0023026">
<property type="term" value="F:MHC class II protein complex binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030955">
<property type="term" value="F:potassium ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0004743">
<property type="term" value="F:pyruvate kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CACAO"/>
</dbReference>
<dbReference type="GO" id="GO:0003723">
<property type="term" value="F:RNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0061621">
<property type="term" value="P:canonical glycolysis"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0032869">
<property type="term" value="P:cellular response to insulin stimulus"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0043312">
<property type="term" value="P:neutrophil degranulation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0012501">
<property type="term" value="P:programmed cell death"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="CDD" id="cd00288">
<property type="entry name" value="Pyruvate_Kinase"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.1380.20">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR001697">
<property type="entry name" value="Pyr_Knase"/>
</dbReference>
<dbReference type="InterPro" id="IPR015813">
<property type="entry name" value="Pyrv/PenolPyrv_Kinase-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR011037">
<property type="entry name" value="Pyrv_Knase-like_insert_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR018209">
<property type="entry name" value="Pyrv_Knase_AS"/>
</dbReference>
<dbReference type="InterPro" id="IPR015793">
<property type="entry name" value="Pyrv_Knase_brl"/>
</dbReference>
<dbReference type="InterPro" id="IPR015795">
<property type="entry name" value="Pyrv_Knase_C"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11817">
<property type="entry name" value="PTHR11817"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00224">
<property type="entry name" value="PK"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF02887">
<property type="entry name" value="PK_C"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR01050">
<property type="entry name" value="PYRUVTKNASE"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF50800">
<property type="entry name" value="SSF50800"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF51621">
<property type="entry name" value="SSF51621"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52935">
<property type="entry name" value="SSF52935"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="TIGRFAMs" id="TIGR01064">
<property type="entry name" value="pyruv_kin"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00110">
<property type="entry name" value="PYRUVATE_KINASE"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0021">Allosteric enzyme</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0324">Glycolysis</keyword>
<keyword id="KW-0379">Hydroxylation</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0460">Magnesium</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0630">Potassium</keyword>
<keyword id="KW-0670">Pyruvate</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="initiator methionine" description="Removed" evidence="20 29 35 43 51">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="Pyruvate kinase PKM" id="PRO_0000112088">
<location>
<begin position="2"/>
<end position="531"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="9 48">
<location>
<begin position="75"/>
<end position="78"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with POU5F1" evidence="40">
<location>
<begin position="307"/>
<end position="531"/>
</location>
</feature>
<feature type="region of interest" description="Intersubunit contact">
<location>
<begin position="389"/>
<end position="433"/>
</location>
</feature>
<feature type="region of interest" description="D-fructose 1,6-bisphosphate binding; part of allosteric site" evidence="1 9 37 48">
<location>
<begin position="432"/>
<end position="437"/>
</location>
</feature>
<feature type="region of interest" description="D-fructose 1,6-bisphosphate binding; part of allosteric site" evidence="1 9 37 48">
<location>
<begin position="516"/>
<end position="521"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Potassium" evidence="9 48">
<location>
<position position="75"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Potassium" evidence="9 48">
<location>
<position position="77"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Potassium" evidence="9 48">
<location>
<position position="113"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Potassium; via carbonyl oxygen" evidence="9 48">
<location>
<position position="114"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Magnesium" evidence="9 48">
<location>
<position position="272"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Magnesium" evidence="9 48">
<location>
<position position="296"/>
</location>
</feature>
<feature type="binding site" description="Serine">
<location>
<position position="70"/>
</location>
</feature>
<feature type="binding site" description="Substrate" evidence="32">
<location>
<position position="73"/>
</location>
</feature>
<feature type="binding site" description="Serine">
<location>
<position position="106"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="9 48">
<location>
<position position="120"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="9 48">
<location>
<position position="207"/>
</location>
</feature>
<feature type="binding site" description="Substrate; via amide nitrogen" evidence="32">
<location>
<position position="270"/>
</location>
</feature>
<feature type="binding site" description="Substrate; via amide nitrogen" evidence="32">
<location>
<position position="295"/>
</location>
</feature>
<feature type="binding site" description="Substrate; via amide nitrogen" evidence="32">
<location>
<position position="296"/>
</location>
</feature>
<feature type="binding site" description="Substrate" evidence="32">
<location>
<position position="328"/>
</location>
</feature>
<feature type="binding site" description="Serine">
<location>
<position position="464"/>
</location>
</feature>
<feature type="binding site" description="D-fructose 1,6-bisphosphate; part of allosteric site" evidence="1 9 37 48">
<location>
<position position="482"/>
</location>
</feature>
<feature type="binding site" description="D-fructose 1,6-bisphosphate; part of allosteric site" evidence="1 9 37 48">
<location>
<position position="489"/>
</location>
</feature>
<feature type="site" description="Transition state stabilizer" evidence="30">
<location>
<position position="270"/>
</location>
</feature>
<feature type="site" description="Crucial for phosphotyrosine binding">
<location>
<position position="433"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylserine" evidence="20 29 51">
<location>
<position position="2"/>
</location>
</feature>
<feature type="modified residue" description="N6,N6,N6-trimethyllysine" evidence="26">
<location>
<position position="3"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="15 16 17 18 19 22 23 24 25 27">
<location>
<position position="37"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="25">
<location>
<position position="41"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="21">
<location>
<position position="62"/>
</location>
</feature>
<feature type="modified residue" description="N6-succinyllysine" evidence="33">
<location>
<position position="66"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="21">
<location>
<position position="89"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="31">
<location>
<position position="97"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="31">
<location>
<position position="100"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="14 25">
<location>
<position position="105"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="25">
<location>
<position position="127"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="33">
<location>
<position position="148"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="21">
<location>
<position position="166"/>
</location>
</feature>
<feature type="modified residue" description="N6-succinyllysine; alternate" evidence="33">
<location>
<position position="166"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="22">
<location>
<position position="175"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="22">
<location>
<position position="195"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="32">
<location>
<position position="249"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="21">
<location>
<position position="266"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="33">
<location>
<position position="270"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="46">
<location>
<position position="305"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="33">
<location>
<position position="322"/>
</location>
</feature>
<feature type="modified residue" description="N6-succinyllysine; alternate" evidence="33">
<location>
<position position="322"/>
</location>
</feature>
<feature type="modified residue" description="4-hydroxyproline" evidence="45">
<location>
<position position="403"/>
</location>
</feature>
<feature type="modified residue" description="4-hydroxyproline" evidence="45">
<location>
<position position="408"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="21">
<location>
<position position="433"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="33">
<location>
<position position="475"/>
</location>
</feature>
<feature type="modified residue" description="N6-succinyllysine" evidence="33">
<location>
<position position="498"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate" evidence="28">
<location>
<position position="166"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_043370" evidence="52">
<original>MSKPHSEAGTAFIQTQQLHAAMADTFLEHMCRLDIDSPPITARNTGIICTIGPASRSVETLKEMIKSGMNVARLNFSHGTHE</original>
<variation>MSPEAQPQRTKGPQQPCRSPIVKPGLPSFRPSSCTQPWLTHSWSTCAAWTLIHHPSQPGTLASSVPL</variation>
<location>
<begin position="1"/>
<end position="82"/>
</location>
</feature>
<feature type="splice variant" description="In isoform M1." id="VSP_011101" evidence="52">
<original>IYHLQLFEELRRLAPITSDPTEATAVGAVEASFKCCSGAIIVLTK</original>
<variation>MFHRKLFEELVRASSHSTDLMEAMAMGSVEASYKCLAAALIVLTE</variation>
<location>
<begin position="389"/>
<end position="433"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17853396." id="VAR_033067" evidence="36">
<original>G</original>
<variation>V</variation>
<location>
<position position="204"/>
</location>
</feature>
<feature type="mutagenesis site" description="Significant reduction in hydroxylation and in PKM-mediated transcriptional activity of HIF1A; when associated with A-408." evidence="45">
<original>P</original>
<variation>A</variation>
<location>
<position position="403"/>
</location>
</feature>
<feature type="mutagenesis site" description="Significant reduction in hydroxylation and in PKM-mediated transcriptional activity of HIF1A; when associated with A-403." evidence="45">
<original>P</original>
<variation>A</variation>
<location>
<position position="408"/>
</location>
</feature>
<feature type="mutagenesis site" description="Unable to bind FBP but still activated by serine." evidence="47">
<original>S</original>
<variation>Y</variation>
<location>
<position position="437"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes serine binding and allosteric activation." evidence="47">
<original>H</original>
<variation>A</variation>
<location>
<position position="464"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 10; AAH12811." ref="10" evidence="53">
<original>E</original>
<variation>Q</variation>
<location>
<position position="7"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; BAG52542." ref="5" evidence="53">
<original>A</original>
<variation>T</variation>
<location>
<position position="54"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAA36672." ref="2" evidence="53">
<original>I</original>
<variation>Y</variation>
<location>
<position position="103"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAA36672." ref="2" evidence="53">
<original>V</original>
<variation>L</variation>
<location>
<position position="132"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 6; BAD96647." ref="6" evidence="53">
<original>Q</original>
<variation>R</variation>
<location>
<position position="187"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 6; BAD96647." ref="6" evidence="53">
<original>H</original>
<variation>R</variation>
<location>
<position position="252"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; CAA39849." ref="4" evidence="53">
<original>R</original>
<variation>P</variation>
<location>
<position position="339"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; BAG52542." ref="5" evidence="53">
<original>A</original>
<variation>V</variation>
<location>
<position position="349"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA36449." ref="1" evidence="53">
<original>H</original>
<variation>N</variation>
<location>
<position position="379"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 10; AAH12811." ref="10" evidence="53">
<original>D</original>
<variation>H</variation>
<location>
<position position="507"/>
</location>
</feature>
<feature type="helix" evidence="13">
<location>
<begin position="15"/>
<end position="17"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="18"/>
<end position="21"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="26"/>
<end position="31"/>
</location>
</feature>
<feature type="strand" evidence="12">
<location>
<begin position="35"/>
<end position="37"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="45"/>
<end position="50"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="53"/>
<end position="55"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="58"/>
<end position="67"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="71"/>
<end position="75"/>
</location>
</feature>
<feature type="helix" evidence="11">
<location>
<begin position="76"/>
<end position="78"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="81"/>
<end position="96"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="97"/>
<end position="100"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="102"/>
<end position="104"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="109"/>
<end position="113"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="119"/>
<end position="121"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="127"/>
<end position="129"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="132"/>
<end position="134"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="139"/>
<end position="143"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="146"/>
<end position="148"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="154"/>
<end position="160"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="164"/>
<end position="167"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="173"/>
<end position="176"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="177"/>
<end position="180"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="181"/>
<end position="188"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="190"/>
<end position="199"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="201"/>
<end position="203"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="204"/>
<end position="206"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="208"/>
<end position="210"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="212"/>
<end position="214"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="223"/>
<end position="234"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="238"/>
<end position="242"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="248"/>
<end position="258"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="259"/>
<end position="264"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="265"/>
<end position="271"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="274"/>
<end position="278"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="280"/>
<end position="286"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="287"/>
<end position="293"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="294"/>
<end position="300"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="303"/>
<end position="305"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="306"/>
<end position="320"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="324"/>
<end position="329"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="332"/>
<end position="335"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="337"/>
<end position="339"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="342"/>
<end position="354"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="357"/>
<end position="362"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="363"/>
<end position="366"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="367"/>
<end position="369"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="371"/>
<end position="387"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="391"/>
<end position="401"/>
</location>
</feature>
<feature type="turn" evidence="7">
<location>
<begin position="402"/>
<end position="404"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="408"/>
<end position="422"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="428"/>
<end position="431"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="433"/>
<end position="435"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="436"/>
<end position="442"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="450"/>
<end position="455"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="457"/>
<end position="462"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="463"/>
<end position="465"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="469"/>
<end position="473"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="482"/>
<end position="499"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="508"/>
<end position="518"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="522"/>
<end position="529"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1T5A"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1ZJH"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3BJT"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3GQY"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3GR4"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3ME3"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3SRF"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4B2D"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4FXF"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4JPG"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4QG6"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4QGC"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4WJ8"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="15592455"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="16964243"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17081983"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18088087"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18691976"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19413330"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19608861"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24129315"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25114211"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25944712"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P00549"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P11980"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P30613"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P52480"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12650930"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12665801"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15996096"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16139798"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17308100"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18191611"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18298799"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18337815"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1854723"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21483450"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21620138"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21700219"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23064226"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23530218"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25263439"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2813362"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source ref="11"/>
</evidence>
<evidence key="52" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000305"/>
<evidence key="54" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="23530218"/>
</source>
</evidence>
<sequence length="531" mass="57937" checksum="AA94D7818ED6BBAD" modified="2007-01-23" version="4">
MSKPHSEAGTAFIQTQQLHAAMADTFLEHMCRLDIDSPPITARNTGIICTIGPASRSVET
LKEMIKSGMNVARLNFSHGTHEYHAETIKNVRTATESFASDPILYRPVAVALDTKGPEIR
TGLIKGSGTAEVELKKGATLKITLDNAYMEKCDENILWLDYKNICKVVEVGSKIYVDDGL
ISLQVKQKGADFLVTEVENGGSLGSKKGVNLPGAAVDLPAVSEKDIQDLKFGVEQDVDMV
FASFIRKASDVHEVRKVLGEKGKNIKIISKIENHEGVRRFDEILEASDGIMVARGDLGIE
IPAEKVFLAQKMMIGRCNRAGKPVICATQMLESMIKKPRPTRAEGSDVANAVLDGADCIM
LSGETAKGDYPLEAVRMQHLIAREAEAAIYHLQLFEELRRLAPITSDPTEATAVGAVEAS
FKCCSGAIIVLTKSGRSAHQVARYRPRAPIIAVTRNPQTARQAHLYRGIFPVLCKDPVQE
AWAEDVDLRVNFAMNVGKARGFFKKGDVVIVLTGWRPGSGFTNTMRVVPVP
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>